share_log

Insider Spends US$204k Buying More Shares In EHealth

Insider Spends US$204k Buying More Shares In EHealth

內部人士花費20.4萬美元購買更多易康股票
Simply Wall St ·  08/12 18:59

Investors who take an interest in eHealth, Inc. (NASDAQ:EHTH) should definitely note that the CEO & Director, Francis Soistman, recently paid US$4.07 per share to buy US$204k worth of the stock. That's a very decent purchase to our minds and it grew their holding by a solid 10%.

對於對易康公司(納斯達克:EHTH)感興趣的投資者,應該注意到該公司的首席執行官兼董事Francis Soistman最近以4.07美元每股的價格購買了20.4萬美元的股票。在我們看來,這是一筆非常不錯的購買,他們的持股增加了穩定的10%。

The Last 12 Months Of Insider Transactions At eHealth

過去12個月易康公司的內部交易記錄

Notably, that recent purchase by Francis Soistman is the biggest insider purchase of eHealth shares that we've seen in the last year. That means that an insider was happy to buy shares at around the current price of US$4.45. That means they have been optimistic about the company in the past, though they may have changed their mind. We do always like to see insider buying, but it is worth noting if those purchases were made at well below today's share price, as the discount to value may have narrowed with the rising price. Happily, the eHealth insiders decided to buy shares at close to current prices.

值得注意的是,Francis Soistman最近的購買是我們在過去一年中看到的易康公司股票最大的內部人士購買。這意味着內部人士願意以約4.45美元的現價購買股票。這意味着他們過去一直對該公司持樂觀態度,但他們的想法可能已經改變。我們總是喜歡看到內部人士購買,但值得注意的是,如果那些購買是在遠低於今天的股價時進行的,因爲折扣到價值的折讓可能隨着上漲的價格而縮小。令人高興的是,易康公司內部人士決定以接近現價的價格購買股票。

In the last twelve months eHealth insiders were buying shares, but not selling. Their average price was about US$4.56. This is nice to see since it implies that insiders might see value around current prices. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

在過去的12個月中,易康公司的內部人員購買了股票,但沒有出售。他們的平均價格約爲4.56美元。這是令人高興的,因爲這意味着內部人士可能看到當前價格周圍的價值。下面的圖表顯示了過去一年中公司和個人的內部交易。如果您想知道究竟是誰以多少錢在何時賣出的,只需點擊下面的圖表即可!

big
NasdaqGS:EHTH Insider Trading Volume August 12th 2024
納斯達克:EHTH股票的內部交易量2024年8月12日

There are always plenty of stocks that insiders are buying. If investing in lesser known companies is your style, you could take a look at this free list of companies. (Hint: insiders have been buying them).

內部人士正在購買的股票是無數的。如果您喜歡投資於較少知名公司,您可以查看此免費的公司列表(提示:內部人士一直在購買它們)。

Does eHealth Boast High Insider Ownership?

易康公司是否擁有高內部持股率?

Many investors like to check how much of a company is owned by insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Insiders own 4.8% of eHealth shares, worth about US$6.3m, according to our data. We do generally prefer see higher levels of insider ownership.

許多投資者喜歡檢查公司有多少股份是由內部人員擁有的。高內部持股往往使公司領導更加關注股東的利益。根據我們的數據,內部人員擁有易康公司的4.8%股份,價值約630萬美元。我們通常更喜歡看到更高水平的內部持股。

What Might The Insider Transactions At eHealth Tell Us?

易康公司內部交易可能告訴我們什麼?

It's certainly positive to see the recent insider purchases. And an analysis of the transactions over the last year also gives us confidence. But we don't feel the same about the fact the company is making losses. We would certainly prefer see higher levels of insider ownership but analysis of the insider transactions suggests that eHealth insiders are expecting a bright future. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. In terms of investment risks, we've identified 3 warning signs with eHealth and understanding them should be part of your investment process.

最近的內部人士購買股票肯定是積極的。過去一年的交易分析也增加了我們的信心。但我們對公司虧損的事實並不感到滿意。我們當然希望看到更高水平的內部持股,但內部交易的分析表明,易康公司內部人士預期有一個輝煌明天。因此,雖然了解內部人員的買賣非常有幫助,但了解一個特定公司面臨的風險也很有幫助。在投資風險方面,我們已確定3個與易康公司有關的警示信號,並且了解它們應該是您的投資過程的一部分。

Of course eHealth may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

當然,易康公司可能不是最好的股票買入選擇。因此,您可能希望查看這個免費的高質量股票的收藏。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

對於本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論